Maximus, Inc. (NYSE:MMS) Insider Ilene R. Baylinson Sells 14,500 Shares

Maximus, Inc. (NYSE:MMS) insider Ilene R. Baylinson sold 14,500 shares of the stock in a transaction dated Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total value of $988,030.00. Following the completion of the transaction, the insider now directly owns 2,512 shares in the company, valued at $171,167.68. This represents a 85.23 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

Maximus Stock Down 2.2 %

Shares of MMS opened at $66.80 on Friday. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82. Maximus, Inc. has a 12 month low of $65.79 and a 12 month high of $93.97. The stock’s 50 day moving average is $73.87 and its two-hundred day moving average is $81.87. The firm has a market cap of $3.78 billion, a P/E ratio of 14.36 and a beta of 0.72.

Maximus (NYSE:MMS) last issued its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, beating the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. Analysts predict that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 28th. Shareholders of record on Saturday, February 15th will be issued a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 1.80%. The ex-dividend date of this dividend is Friday, February 14th. Maximus’s payout ratio is currently 25.81%.

Analyst Ratings Changes

Several analysts recently commented on the company. Raymond James raised Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 target price on the stock in a report on Thursday, January 2nd. StockNews.com lowered Maximus from a “buy” rating to a “hold” rating in a report on Friday, February 14th.

Institutional Trading of Maximus

Institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. lifted its position in shares of Maximus by 3.2% in the fourth quarter. Vanguard Group Inc. now owns 6,548,284 shares of the health services provider’s stock valued at $488,829,000 after acquiring an additional 205,564 shares in the last quarter. Mackenzie Financial Corp lifted its position in shares of Maximus by 2.0% in the fourth quarter. Mackenzie Financial Corp now owns 2,782,150 shares of the health services provider’s stock valued at $207,687,000 after acquiring an additional 55,583 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of Maximus by 1.4% in the third quarter. Geode Capital Management LLC now owns 1,525,159 shares of the health services provider’s stock valued at $142,109,000 after acquiring an additional 21,532 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in shares of Maximus by 14.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,406,592 shares of the health services provider’s stock valued at $105,001,000 after acquiring an additional 177,075 shares in the last quarter. Finally, Van Berkom & Associates Inc. lifted its position in shares of Maximus by 8.5% in the fourth quarter. Van Berkom & Associates Inc. now owns 1,256,418 shares of the health services provider’s stock valued at $93,792,000 after acquiring an additional 98,264 shares in the last quarter. 97.21% of the stock is owned by institutional investors and hedge funds.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.